p53 (TP53) Human shRNA Plasmid Kit (Locus ID 7157)
CAT#: TR320558
TP53 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 5 publications. |
Product images
经常一起买 (2)
TP53 mouse monoclonal antibody, clone OTI5E2 (formerly 5E2)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | p53 (TP53) Human shRNA Plasmid Kit (Locus ID 7157) |
Locus ID | 7157 |
UniProt ID | P04637 |
Synonyms | BCC7; BMFS5; LFS1; P53; TRP53 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | TP53 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 7157). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_000546, NM_001126112, NM_001126113, NM_001126114, NM_001126115, NM_001126116, NM_001126117, NM_001126118, NM_001276695, NM_001276696, NM_001276697, NM_001276698, NM_001276699, NM_001276760, NM_001276761, NM_000546.1, NM_000546.2, NM_000546.3, NM_000546.4, NM_000546.5, NM_001126116.1, NM_001126117.1, NM_001126115.1, NM_001126114.1, NM_001126114.2, NM_001126113.1, NM_001126113.2, NM_001126112.1, NM_001126112.2, NM_001276696.1, NM_001276695.1, NM_001126118.1, NM_001276760.1, NM_001276761.1, NM_001276698.1, NM_001276699.1, NM_001276697.1, BC003596, BC003596.1, NM_000546.6, NM_001276761.2, NM_001276699.2, NM_001276696.2, NM_001276698.2, NM_001276697.2, NM_001276695.2, NM_001276760.2 |
Summary | This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs/particles at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection/transduction efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection/transduction. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected/tranduced samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs/particles, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection/transduction efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (5)
The use of this RNAi has been cited in the following citations: |
---|
TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background
,Caratozzolo, MF;Marzano, F;Abbrescia, DI;Mastropasqua, F;Petruzzella, V;Calabrò, V;Pesole, G;Sbisà, E;Guerrini, L;Tullo, A;,
Front Oncol
,PubMed ID 31781486
[TP53]
|
p53 is essential for embelin-induced apoptosis in p53-wildtype prostate cancer cells
,Wang, S;Zhao, Y;Chen, L;Liu, C;,
Int J Clin Exp Med
[TP53]
|
Harnessing the p53-PUMA Axis to Overcome DNA Damage Resistance in Renal Cell Carcinoma
,Zhou, X;Tolstov, Y;Arslan, A;Roth, W;Grüllich, C;Pahernik, S;Hohenfellner, M;Duensing, S;,
Neoplasia
,PubMed ID 25499216
[TP53]
|
Oncomorphic TP53 Mutations in Gynecologic Cancers Lose the Normal Protein: Protein Interactions with the microRNA Microprocessing Complex
,Brachova, P;Mueting, SR;Devor, EJ;,
Journal of Cancer Therapy April 2014
[TP53]
|
Downregulation of SMG-1 in HPV-Positive Head and Neck Squamous Cell Carcinoma Due to Promoter Hypermethylation Correlates with Improved Survival
,Evgenia Gubanova, Brandee Brown, Sergei V. Ivanov, Thomas Helleday, Gordon B. Mills, Wendell G. Yarbrough, and Natalia Issaeva,
Clin. Cancer Res., Mar 2012; 18: 1257 - 1267.
[TP53]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...